> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# No Major Changes at FDA: Pines
- URL: https://www.fdaweb.com/no-major-changes-at-fda-pines/
- Published: 2016-11-10T12:00:00.000Z
- Updated: 2026-09-14T21:46:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137307

Former FDAer **Wayne Pines**, now Apco president of healthcare, says he expects that under President **Donald Trump** FDA will be similar in nature to the agency it is today, but with new leadership. In a brief [video](http://apcoworldwide.com/blog/detail/apcoforum/2016/11/09/how-the-2016-impact-the-fda?ref=fdaweb.com), Pines outlines three impacts he believes the election results will have on FDA: 

- the agency will remain mission-driven because everyone wants safe food and safe and effective drugs and medical devices;
- appointment of a new commissioner and possibly also a change in other senior officials; and
- a continuing emphasis on expediting approval of new drugs and medical devices, including new generic drugs, an emphasis that he says would have continued no matter who won the election.